121 related articles for article (PubMed ID: 20036815)
21. Role of G protein-coupled receptor kinase 2 in tumoral angiogenesis.
Rivas V; Nogués L; Reglero C; Mayor F; Penela P
Mol Cell Oncol; 2014; 1(4):e969166. PubMed ID: 27308373
[TBL] [Abstract][Full Text] [Related]
22. Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.
Sento S; Sasabe E; Yamamoto T
PLoS One; 2016; 11(2):e0148454. PubMed ID: 26849680
[TBL] [Abstract][Full Text] [Related]
23. Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy.
Volk-Draper LD; Rajput S; Hall KL; Wilber A; Ran S
Neoplasia; 2012 Oct; 14(10):926-42. PubMed ID: 23097627
[TBL] [Abstract][Full Text] [Related]
24. Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.
Ran S; Montgomery KE
Cancers (Basel); 2012 Sep; 4(3):618-57. PubMed ID: 22946011
[TBL] [Abstract][Full Text] [Related]
25. The role of chemokines and their receptors in angiogenesis.
Kiefer F; Siekmann AF
Cell Mol Life Sci; 2011 Sep; 68(17):2811-30. PubMed ID: 21479594
[TBL] [Abstract][Full Text] [Related]
26. Anti-angiogenic peptides for cancer therapeutics.
Rosca EV; Koskimaki JE; Rivera CG; Pandey NB; Tamiz AP; Popel AS
Curr Pharm Biotechnol; 2011 Aug; 12(8):1101-16. PubMed ID: 21470139
[TBL] [Abstract][Full Text] [Related]
27. In pursuit of new anti-angiogenic therapies for cancer treatment.
Cai J; Han S; Qing R; Liao D; Law B; Boulton ME
Front Biosci (Landmark Ed); 2011 Jan; 16(3):803-14. PubMed ID: 21196204
[TBL] [Abstract][Full Text] [Related]
28. Human endothelial stem/progenitor cells, angiogenic factors and vascular repair.
Watt SM; Athanassopoulos A; Harris AL; Tsaknakis G
J R Soc Interface; 2010 Dec; 7 Suppl 6(Suppl 6):S731-51. PubMed ID: 20843839
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of tumors cell growth in osteosarcoma-bearing SD rats through a combination of conventional and metronomic scheduling of neoadjuvant chemotherapy.
Zhu XZ; Yin HM; Mei J
Acta Pharmacol Sin; 2010 Aug; 31(8):970-6. PubMed ID: 20686521
[TBL] [Abstract][Full Text] [Related]
30. Delta-like 4/Notch signaling promotes Apc
Badenes M; Trindade A; Pissarra H; Lopes-da-Costa L; Duarte A
BMC Cancer; 2017 Jan; 17(1):50. PubMed ID: 28086833
[TBL] [Abstract][Full Text] [Related]
31. Regulation of tumor angiogenesis by the local environment.
Hall K; Ran S
Front Biosci (Landmark Ed); 2010 Jan; 15(1):195-212. PubMed ID: 20036815
[TBL] [Abstract][Full Text] [Related]
32. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
33. Dll4-Notch signaling in regulation of tumor angiogenesis.
Liu Z; Fan F; Wang A; Zheng S; Lu Y
J Cancer Res Clin Oncol; 2014 Apr; 140(4):525-36. PubMed ID: 24114288
[TBL] [Abstract][Full Text] [Related]
34. Angiogenic and lymphangiogenic cascades in the tumor microenvironment.
Onimaru M; Yonemitsu Y
Front Biosci (Schol Ed); 2011 Jan; 3(1):216-25. PubMed ID: 21196371
[TBL] [Abstract][Full Text] [Related]
35. Targeting angiogenesis in cancer therapy.
Ichihara E; Kiura K; Tanimoto M
Acta Med Okayama; 2011 Dec; 65(6):353-62. PubMed ID: 22189475
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
